Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference
The Pharma Data
MAY 7, 2021
Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 9:40 a.m. Remarketing tags may not be associated with personally identifiable information or placed on pages related to sensitive categories. Eastern Time). You are now leaving jnj.com.
Let's personalize your content